Trouble in Prozac Nation

By Richard DeGrandpre

This article appeared in the January 5, 2004 edition of The Nation.

December 18, 2003

The possibility that a group of widely prescribed antidepressants, including Prozac and Paxil, might trigger suicide and other violence in a small percentage of users has been the subject of isolated reports in the major media since they first arrived on the market. Recently, however, the concern has been recognized by the federal government. In June, following actions taken by British drug authorities, the FDA released a statement recommending that physicians refrain from prescribing Paxil to new patients under 18.

Paxil is one of a class of drugs known as selective serotonin reuptake inhibitors (SSRIs). Studies funded by the drug's maker, GlaxoSmithKline (GSK), showed it was no more effective than placebos for treating pediatric depression. The same studies also showed an increased occurrence of emotional disturbance in those taking it. The likelihood of a suicide attempt, for example, was about three times greater for Paxil users than for those taking placebos. In August, Wyeth pharmaceuticals drew essentially the same conclusions about its antidepressant Effexor, sending out a two-page letter to healthcare workers stating it may not be safe for pediatric use. This led to the FDA's reanalyzing data for Effexor and several other SSRIs, and in October the FDA issued an advisory citing similar findings for Celexa, Effexor, Prozac and Zoloft. In December drug authorities in Britain banned all but one SSRI from use by children because of evidence that they can cause children to become suicidal. The consistency of these findings suggests that perhaps the FDA should be taking actions that should have been taken long ago to curb adult use of SSRIs.

Reports of a possible link between adult SSRI use and violence, including suicide, first appeared in 1990. In 1991, however, the FDA made a finding, based on a highly selective set of data put together by Eli Lilly scientists, which concluded that Prozac did not cause suicide and was safe. Since that time, SSRI makers have dismissed all allegations that the drugs cause violence and suicide by citing the FDA's report--a report that now looks especially dubious in light of concerns over giving these drugs to children.

Subscriber Login

4 ISSUES FREE

Subscribe Now!

The only way to read this article and the full contents of each week's issue of The Nation online is by subscribing to the magazine. Subscribe now and read this article -- and every article published since for the past five years -- right now.

There's no obligation -- try The Nation for four weeks free.

.

About Richard DeGrandpre

Richard DeGrandpre is the author of Ritalin Nation (Norton), as well as the investigative report “The Lilly Suicides,” available at http://prozacspotlight.org/lilly. more...
Advertisement
Advertisement
Advertisement

Blogs

» The Beat

Palin Goes Gonzo | Quitting as governor but still talking about "campaigning," the GOP's wild woman from Wasilla tries to out-weird Mark Sanford.
John Nichols
20 Comments
Posted at 4:47 PM ET

» The Notion

Celebrating the Fourth by Remembering the Fifth | On Independence Day, the forgotten and imperiled Fifth Amendment bears honoring.
Eyal Press
8 Comments

» Editor's Cut

Obama in Moscow | The President will give an interview to Russia's leading opposition newspaper Novaya Gazeta. to mark his visit there on Monday. This is very good news.
Katrina vanden Heuvel
28 Comments

» Altercation

Mikey 'n' Me | I got closer to Michael Jackson than almost anyone, or at least closer than most people of the age of consent.
Eric Alterman

» Capitolism

Washington: Even More Corrupt Than You Thought! | Washington Post sells access to lobbyists.
Christopher Hayes
56 Comments

» The Dreyfuss Report

Whisky Tango Foxtrot? | General Jones tells the generals in Kabul: don't bother asking for more troops.
Robert Dreyfuss
63 Comments

» Act Now!

Food Independence Day | Celebrate America's independence by feasting on locally grown food on July 4.
Peter Rothberg
40 Comments